Please use this identifier to cite or link to this item:
https://doi.org/10.1038/ncomms15028
DC Field | Value | |
---|---|---|
dc.title | Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models | |
dc.contributor.author | Hwang, I.Y | |
dc.contributor.author | Koh, E | |
dc.contributor.author | Wong, A | |
dc.contributor.author | March, J.C | |
dc.contributor.author | Bentley, W.E | |
dc.contributor.author | Lee, Y.S | |
dc.contributor.author | Chang, M.W | |
dc.date.accessioned | 2020-09-04T03:41:02Z | |
dc.date.available | 2020-09-04T03:41:02Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Hwang, I.Y, Koh, E, Wong, A, March, J.C, Bentley, W.E, Lee, Y.S, Chang, M.W (2017). Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models. Nature Communications 8 : 15028. ScholarBank@NUS Repository. https://doi.org/10.1038/ncomms15028 | |
dc.identifier.issn | 2041-1723 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/174427 | |
dc.description.abstract | Bacteria can be genetically engineered to kill specific pathogens or inhibit their virulence. We previously developed a synthetic genetic system that allows a laboratory strain of Escherichia coli to sense and kill Pseudomonas aeruginosa in vitro. Here, we generate a modified version of the system, including a gene encoding an anti-biofilm enzyme, and use the probiotic strain Escherichia coli Nissle 1917 as host. The engineered probiotic shows in vivo prophylactic and therapeutic activity against P. aeruginosa during gut infection in two animal models (Caenorhabditis elegans and mice). These findings support the further development of engineered microorganisms with potential prophylactic and therapeutic activities against gut infections. © 2017 The Author(s). | |
dc.publisher | Nature Publishing Group | |
dc.source | Unpaywall 20200831 | |
dc.subject | alanine racemase | |
dc.subject | probiotic agent | |
dc.subject | probiotic agent | |
dc.subject | bacterium | |
dc.subject | biofilm | |
dc.subject | enzyme activity | |
dc.subject | genetic engineering | |
dc.subject | infectivity | |
dc.subject | nematode | |
dc.subject | pathogen | |
dc.subject | probiotics | |
dc.subject | rodent | |
dc.subject | virulence | |
dc.subject | animal experiment | |
dc.subject | animal model | |
dc.subject | animal tissue | |
dc.subject | Article | |
dc.subject | bacterial strain | |
dc.subject | Caenorhabditis elegans | |
dc.subject | controlled study | |
dc.subject | drug efficacy | |
dc.subject | Escherichia coli | |
dc.subject | Escherichia coli Nissle 1917 | |
dc.subject | female | |
dc.subject | genetic engineering | |
dc.subject | in vivo study | |
dc.subject | infection prevention | |
dc.subject | intestine infection | |
dc.subject | mouse | |
dc.subject | nonhuman | |
dc.subject | Pseudomonas infection | |
dc.subject | treatment outcome | |
dc.subject | animal | |
dc.subject | disease model | |
dc.subject | Escherichia coli | |
dc.subject | gastroenteritis | |
dc.subject | genetic engineering | |
dc.subject | genetics | |
dc.subject | Institute for Cancer Research mouse | |
dc.subject | microbiology | |
dc.subject | pathogenicity | |
dc.subject | procedures | |
dc.subject | Pseudomonas aeruginosa | |
dc.subject | Pseudomonas infection | |
dc.subject | transgenic microorganism | |
dc.subject | virulence | |
dc.subject | Animalia | |
dc.subject | Bacteria (microorganisms) | |
dc.subject | Caenorhabditis elegans | |
dc.subject | Escherichia coli | |
dc.subject | Escherichia coli Nissle 1917 | |
dc.subject | Mus | |
dc.subject | Pseudomonas aeruginosa | |
dc.subject | Animals | |
dc.subject | Caenorhabditis elegans | |
dc.subject | Disease Models, Animal | |
dc.subject | Escherichia coli | |
dc.subject | Female | |
dc.subject | Gastroenteritis | |
dc.subject | Genetic Engineering | |
dc.subject | Mice | |
dc.subject | Mice, Inbred ICR | |
dc.subject | Microorganisms, Genetically-Modified | |
dc.subject | Probiotics | |
dc.subject | Pseudomonas aeruginosa | |
dc.subject | Pseudomonas Infections | |
dc.subject | Virulence | |
dc.type | Article | |
dc.contributor.department | BIOCHEMISTRY | |
dc.contributor.department | PAEDIATRICS | |
dc.description.doi | 10.1038/ncomms15028 | |
dc.description.sourcetitle | Nature Communications | |
dc.description.volume | 8 | |
dc.description.page | 15028 | |
Appears in Collections: | Elements Staff Publications |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1038_ncomms15028.pdf | 1.37 MB | Adobe PDF | OPEN | None | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.